Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
Deciphering the mechanisms of the pathogenesis of immune-mediated inflammatory rheumatic diseases (IIRDs) and designing a wide range of biological agents (BAs) are the major achievements of 21st century medicine. A new promising area of pharmacotherapy for IIRDs is associated with the design of so-c...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
IMA PRESS LLC
2020-02-01
|
| Serier: | Научно-практическая ревматология |
| Fag: | |
| Online adgang: | https://rsp.mediar-press.net/rsp/article/view/2845 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|